Current status of clinical research courses in India

 

Our holy writ of great sages who had deep understandings in different fields along with medicine. If we talk about current era for the field of medicine, agriculture, history, science etc. we have number journals, academic research and thesis of experts and scientists. To determine the future of any field the relevance of publications has always been the key factor. If we talk about the clinical research courses which is the need of the today’s era it include the three types of research— treatment, prevention and the diagnostic. These three clinical research factors examine diseases from a unique perspective in order to improve the patient health.

The ongoing structure of clinical research courses in India

In 2021, India authorized approximately 100 worldwide clinical studies and was found to be the highest record since 2013. India also hosted about 87 worldwide clinical studies in 2020 during the event of COVID crisis. The New Drug and Clinical Trials [NDCT] guidelines have been passed to manage the proper clinical research policy by India in March 2019. During the pandemic, India has shown tremendous growth in clinical testing studies when compared with the average of a decade from 6.2% to 8.3%. The foremost therapy domain was contagious diseases with the contribution of a 32.5% share.

Challenges faced in the industry of clinical research

The current need is to manage the issues regarding the studies and the publications as they are major contributors in clinical trial phases. As per the industrial observations, the need to carry out the research has been put forth. The inefficiencies regarding the current scientific or research are lagging and are found to be not able to solve the nation’s persistent problems. The key issues for this are disinterest, no dedication, facilities, equipment, funding, rewards, restrictions imposed with this they are lacking the experienced research faculty to supervise students. There is need to learn about the pharmacovigilance as per the growth of clinical research sector. Until and unless they we will examine the effects and side effects about certain clinical trial if they are not aware of the related side effects. Thus, there is a need of learning the pharmacovigilance course in order to adapt the perspective of drug as well as patient safety.

There are number of Clinical research courses available that try to improve the skills of the ambitious students but the results can only be achieved when the students put their efforts. The strict initiative has been imposed to highlight this issue. There is compulsion for the PG [MD/MS] and doctoral [DM/MCh] programs to provide the observational study education for research and to support the contributors for future important clinical steps. But the rule has been sanctioned to take the entrance test at several medical institutions as an ‘’academic formality’’.  According to this the Medical Council of India has made mandatory to present and publish minimum one research paper throughout the postgraduate courses. This is found to be the one of the most compulsory requirements for appearing in degree examinations.

Conclusion

The way for the better performance of clinical research and tackling India’s healthcare concerns requires a turn for the medical student and the faculty member regarding the academic behavior. It can be solved if we establish appropriate research queries highlighting to improve the needs of patients. For the sake of more sustainable healthcare system, we must encourage and improvise the overall medical research and the published content. We never know that we will come up with a legendary invention!

Regulatory affairs courses